Research progress of cognitive function decline in patients with coronary heart disease

doi:10.3969/j.issn.1006-7795.2025.03.014

Abstract

Abstract: Coronary heart disease (CHD) imposes a high disease burden in China and it is still increasing significantly. There is a two-way connection between the heart and the brain, and the premature and rapid decline of cognitive function in patients with CHD has attracted increasing interesting from researchers, but clinical professionals often pay more attention to heart-related symptoms and ignore the impact of cognitive function decline on the quality of life of patients with CHD. This article reviews the current research progresses of cognitive decline in CHD patients from the aspects of manifestation, influencing factors, pathological mechanism and intervention measures. It offers a reference for medical professionals to understand this problem more deeply.

Key words: coronary heart disease, cognitive function, heart-brain connection, pathological mechanism, research progress

CLC Number:

R749

Huo Bixiu, Jia Hongxiao, , Ning Yanzhe. Research progress of cognitive function decline in patients with coronary heart disease[J]. Journal of Capital Medical University, 2025, 46(3): 496-502.

References

［1］Moerschel K S, De Bacquer D, De Backer G, et al. Assessing the probability of risk factor control in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey［J］. Eur J Prev Cardiol, 2022, 29(10): 1465－1475.
［2］Roy E, Psych C. Cognitive function［M］//Gellman M D, Turner J R. Encyclopedia of Behavioral Medicine. New York: Springer, 2013: 448－449.
［3］Eggermont L H P, de Boer K, Muller M, et al. Cardiac disease and cognitive impairment: a systematic review［J］. Heart, 2012, 98(18): 1334－1340.
［4］Haring B, Leng X Y, Robinson J, et al. Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study［J］. J Am Heart Assoc, 2013, 2(6): e000369.
［5］Volonghi I, Pendlebury S T, Welch S J V, et al. Cognitive outcomes after acute coronary syndrome: a population based comparison with transient ischaemic attack and minor stroke［J］. Heart, 2013, 99(20): 1509－1514.
［6］Ikram M A, Hollander M, Bos M J, et al. Unrecognized myocardial infarction and the risk of stroke: the Rotterdam Study［J］. Neurology, 2006, 67(9): 1635－1639.
［7］Barclay L L, Weiss E M, Mattis S, et al. Unrecognized cognitive impairment in cardiac rehabilitation patients［J］. J Am Geriatr Soc, 1988, 36(1): 22－28.
［8］Zheng L, Mack W J, Chui H C, et al. Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults［J］. J Am Geriatr Soc, 2012, 60(3): 499－504.
［9］Singh-Manoux A, Sabia S, Lajnef M, et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall Ⅱ study［J］. Eur Heart J, 2008, 29(17): 2100－2107.
［10］Liang J,Pan Y, Zhang W Y, et al. Associations between atherosclerosis and subsequent cognitive decline: a prospective cohort study［J］. J Am Heart Assoc, 2024, 13(21): e036696.
［11］Vishwanath S, Hopper I, Wolfe R, et al. Cognitive trajectories and incident dementia after a cardiovascular event in older adults［J］. Alzheimers Dement, 2023, 19(8): 3670－3678.
［12］Weinstein G, Goldbourt U, Tanne D. Angina pectoris severity among coronary heart disease patients is associated with subsequent cognitive impairment［J］. Alzheimer Dis Assoc Disord, 2015, 29(1): 6－11.
［13］Narvaez Linares N F, Poitras M, Burkauskas J, et al. Neuropsychological sequelae of coronary heart disease in women: a systematic review［J］. Neurosci Biobehav Rev, 2021, 127: 837－851.
［14］Deckers K, Schievink S H J, Rodriquez M M F, et al. Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis［J］. PLoS One, 2017, 12(9): e0184244.
［15］Roberts R O, Knopman D S, Geda Y E, et al. Coronary heart disease is associated with non-amnestic mild cognitive impairment［J］. Neurobiol Aging, 2010, 31(11): 1894－1902.
［16］Stewart R A H, Held C, Krug-Gourley S, et al. Cardiovascular and lifestyle risk factors and cognitive function in patients with stable coronary heart disease［J］. J Am Heart Assoc, 2019, 8(7): e010641.
［17］Evans D A, Beckett L A, Albert M S, et al. Level of education and change in cognitive function in a community population of older persons［J］. Ann Epidemiol, 1993, 3(1): 71－77.
［18］Xia C Y, Vonder M, Sidorenkov G, et al. Coronary artery calcium and cognitive function in dutch adults: cross-sectional results of the population-based ImaLife study［J］. J Am Heart Assoc, 2021, 10(4): e018172.
［19］Xie W, Zheng F, Yan L, et al.Cognitive decline before and after incident coronary events［J］. J Am Coll Cardiol, 2019, 73(24): 3041－3050.
［20］Jinawong K, Apaijai N, Piamsiri C, et al. Mild cognitive impairment occurs in rats during the early remodeling phase of myocardial infarction［J］. Neuroscience, 2022, 493: 31－40.
［21］Gottesman R F, Grega M A, Bailey M M, et al. Association between hypotension, low ejection fraction and cognitive performance in cardiac patients［J］. Behav Neurol, 2010, 22(1/2): 63－71.
［22］Almeida O P, Beer C, Lautenschlager N T, et al. Two-year course of cognitive function and mood in adults with congestive heart failure and coronary artery disease: the heart-mind study［J］. Int Psychogeriatr, 2012, 24(1): 38－47.
［23］Greaves D, Psaltis P J, Davis D H J, et al. Risk factors for delirium and cognitive decline following coronary artery bypass grafting surgery: a systematic review and meta-analysis［J］. J Am Heart Assoc, 2020, 9(22): e017275.
［24］Greaves D, Psaltis P J, Ross T J, et al. Cognitive outcomes following coronary artery bypass grafting: a systematic review and meta-analysis of 91,829 patients［J］. Int J Cardiol, 2019, 289: 43－49.
［25］Newman M F, Kirchner J L, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery［J］. N Engl J Med, 2001, 344(6): 395－402.
［26］Holinski S, Claus B, Barajas T, et al. Cerebroprotective effect of preoperative dual antiplatelet therapy in patients undergoing coronary bypass surgery［J］. Ann Thorac Cardiovasc Surg, 2014, 20(1): 38－43.
［27］Sundbøll J, Horváth-Puhó E, Adelborg K, et al. Higher risk of vascular dementia in myocardial infarction survivors［J］. Circulation, 2018, 137(6): 567－577.
［28］Duijndam S, Denollet J, Nyklícˇek I, et al. Perceived cognition after percutaneous coronary intervention: association with quality of life, mood and fatigue in the THORESCI study［J］. Int J Behav Med, 2017, 24(4): 552－562.
［29］Jurga J, Tornvall P, Dey L. Does coronary angiography and percutaneous coronary intervention affect cognitive function?［J］. Am J Cardiol, 2016, 118(10): 1437－1441.
［30］Selnes O A, Grega M A, Bailey M M, et al. Do management strategies for coronary artery disease influence 6-year cognitive outcomes?［J］. Ann Thorac Surg, 2009, 88(2): 445－454.
［31］L. Lanctôt K, O'Regan J, Schwartz Y, et al. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease［J］. Psychosomatics, 2014, 55(1): 61－68.
［32］Burkauskas J, Noreikaite A, Bunevicius A, et al. Beta-1-selective beta-blockers and cognitive functions in patients with coronary artery disease: a cross-sectional study［J］. J Neuropsychiatry Clin Neurosci, 2016, 28(2): 143－146.
［33］Hilkens N A, Algra A, Kappelle L J, et al. Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke［J］. Neurology, 2018, 90(8): e683－e689.
［34］Le D, Brown L, Malik K, et al. Two opposing functions of angiotensin-converting enzyme (ACE) that links hypertension, dementia, and aging［J］. Int J Mol Sci, 2021, 22(24): 13178.
［35］Wu Y N, Chen L W, Zhong F, et al. Cognitive impairment in patients with heart failure: molecular mechanism and therapy［J］. Heart Fail Rev, 2023, 28(4): 807－820.
［36］Hu Z C, Ding L G, Yao Y. Atrial fibrillation: mechanism and clinical management［J］. Chin Med J (Engl), 2023, 136(22): 2668－2676.
［37］Benjamin E J, Virani S S, Callaway C W, et al. Heart disease and stroke statistics－2018 update: a report from the American heart association［J］. Circulation, 2018, 137(12): e493.
［38］Mun H, Shim J Y, Kimm H, et al. Associations between Korean coronary heart disease risk score and cognitive function in dementia-free Korean older adults［J］. J Korean Med Sci, 2023, 38(2): e11.
［39］Testai F D, Gorelick P B, Chuang P Y, et al. Cardiac contributions to brain health: a scientific statement from the american heart association［J］. Stroke, 2024, 55(12): e425－e438.
［40］Tini G, Scagliola R, Monacelli F, et al. Alzheimers disease and cardiovascular disease: a particular association［J］. Cardiol Res Pract, 2020, 2020: 2617970.
［41］Yun M, Nie B, Wen W, et al. Assessment of cerebral glucose metabolism in patients with heart failure by 18F-FDG PET/CT imaging［J］. J Nucl Cardiol, 2022, 29(2): 476－488.
［42］Haratz S, Weinstein G, Molshazki N, et al. Impaired cerebral hemodynamics and cognitive performance in patients with atherothrombotic disease［J］. J Alzheimers Dis, 2015, 46(1): 137－144.
［43］Shah A, Chen C, Campanella C, et al. Brain correlates of stress-induced peripheral vasoconstriction in patients with cardiovascular disease［J］. Psychophysiology, 2019, 56(2): e13291.
［44］Kempuraj D, Dourvetakis K D, Cohen J, et al. Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders［J］. Front Cell Neurosci, 2024, 18: 1491952.
［45］Tan Z S, Beiser A S, Fox C S, et al. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study［J］. Diabetes Care, 2011, 34(8): 1766－1770.
［46］Stakos D A, Stamatelopoulos K, Bampatsias D, et al. The Alzheimer's disease amyloid-beta hypothesis in cardiovascular aging and disease: JACC focus seminar［J］. J Am Coll Cardiol, 2020, 75(8): 952－967.
［47］Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease［J］. Neuron, 2017, 96(1): 17－42.
［48］Severino P, D'Amato A, Pucci M, et al. Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction［J］. Int J Mol Sci, 2020, 21(21): 8118.
［49］Zhao B X, Li T F, Fan Z R, et al. Heart-brain connections: phenotypic and genetic insights from magnetic resonance images［J］. Science, 2023, 380(6648): abn6598.
［50］Hagenaars S P, Harris S E, Clarke T K, et al. Polygenic risk for coronary artery disease is associated with cognitive ability in older adults［J］. Int J Epidemiol, 2016, 45(2): 433－440.
［51］de Silva E, Sudre C H, Barnes J, et al. Polygenic coronary artery disease association with brain atrophy in the cognitively impaired［J］. Brain Commun, 2022, 4(6): fcac314.
［52］Stanek K M, Gunstad J, Spitznagel M B, et al. Improvements in cognitive function following cardiac rehabilitation for older adults with cardiovascular disease［J］. Int J Neurosci, 2011, 121(2): 86－93.
［53］Bethge M, Thome-Soós F, Raóo L M, et al. Cognitive-behavioral rehabilitation in patients with cardiovascular diseases: a randomized controlled trial (CBR-CARDIO, DRKS00029295)［J］. BMC Cardiovasc Disord, 2023, 23(1): 252.
［54］Saklıca D, Vardar-Yagˇli N, Ateş A H, et al. Does cognitive function affect functional capacity and perceived fatigue severity after exercise in patients with coronary artery disease?［J］. Physiother Res Int, 2024, 29(4): e2139.
［55］Saleem M, Herrmann N, Dinoff A, et al. Association between endothelial function and cognitive performance in patients with coronary artery disease during cardiac rehabilitation［J］. Psychosom Med, 2019, 81(2): 184－191.
［56］Anazodo U C, Shoemaker J K, Suskin N, et al. An investigation of changes in regional gray matter volume in cardiovascular disease patients, pre and post cardiovascular rehabilitation［J］. Neuroimage Clin, 2013, 3: 388－395.
［57］Anazodo U C, Shoemaker J K, Suskin N, et al. Impaired cerebrovascular function in coronary artery disease patients and recovery following cardiac rehabilitation［J］. Front Aging Neurosci, 2015, 7: 224.
［58］Bérubé B, Boidin M, Gayda M, et al. Acute effects of exercise on cerebrovascular response and cognitive performance in individuals with stable coronary heart disease［J］. Brain Res, 2021, 1772: 147671.
［59］Li Y L. Stellate ganglia and cardiac sympathetic overactivation in heart failure［J］. Int J Mol Sci, 2022, 23(21): 13311.
［60］Zhang J, Liu Y, Li H J, et al. Stellate ganglion block improves postoperative cognitive dysfunction in aged rats by SIRT1-mediated white matter lesion repair［J］. Neurochem Res, 2022, 47(12): 3838－3853.
［61］Williamson J D, Pajewski N M, Auchus A P, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial［J］. JAMA, 2019, 321(6): 553－561.
［62］Hajduk A M, Saczynski J S, Tsang S, et al. Presentation, treatment, and outcomes of older adults hospitalized for acute myocardial infarction according to cognitive status: the SILVER-AMI study［J］. Am J Med, 2021, 134(7): 910－917.
［63］Ishihara K, Izawa K P, Kitamura M, et al. Impact of mild cognitive impairment on unplanned readmission in patients with coronary artery disease［J］. Eur J Cardiovasc Nurs, 2022, 21(4): 348－355.

[1]	Huo Bixiu, Jia Hongxiao, , Ning Yanzhe, Zheng Sisi. Abnormal top-down and bottom-up attention patterns in patients suffering from coronary heart disease with heart qi deficiency syndrome [J]. Journal of Capital Medical University, 2025, 46(3): 455-462.
[2]	Li Xingmao, Li Xiu, Wang Ting, Zhao Xin, Wang Deyang, Shang Haiyan, Zhao Yongmei, Li Sen. Effects of GLP-1 receptor agonists on cognitive function in patients with type 2 diabetes mellitus after acute ischemic stroke [J]. Journal of Capital Medical University, 2024, 45(6): 1029-1037.
[3]	Jiang Huan , Li Jiaoqing, Xu Haosen , Lan Jinyi , Yang Shanzhi , Zhang Ting , Liu Peimin , Wu Danfeng , Bai Xiaoyan. Research progression of slit guidance ligand 3 [J]. Journal of Capital Medical University, 2024, 45(5): 917-922.
[4]	Hao Zhuohong, Yun Duo, Zhang Ying, Li Huihui, Lin Haishan, Cui Yong, Zhao Lei. Advances in research of perioperative immunotherapy for non-small cell lung cancer—advances in neoadjuvant immunotherapy [J]. Journal of Capital Medical University, 2024, 45(4): 666-677.
[5]	Hou Dongyan, Feng Dan, Li Na. Efficacy of dapagliflozin in treatment of coronary heart disease and heart failure with preserved ejection fraction patients [J]. Journal of Capital Medical University, 2024, 45(4): 715-720.
[6]	Zhu Lin, Xu Yongsong, Feng Xiaotong, Zhao Dong, Ke Jing. Progresses in the drug treatment of diabetic retinopathy [J]. Journal of Capital Medical University, 2024, 45(3): 438-445.
[7]	Dai Zhiqing, Lin Jin, Duan Yuhang, Teng Fei, Lyu Hongpeng, Jia Hongxiao. A study on the differences of cognitive functions between individuals dominated by Wood Element and Metal Element among the Five Elements people [J]. Journal of Capital Medical University, 2024, 45(3): 458-465.
[8]	Teng Fei, Song Mingkang, Lyu Hongpeng, Jia Hongxiao. Research progresses on the correlation between personality traits and cognitive function [J]. Journal of Capital Medical University, 2024, 45(3): 466-471.
[9]	Duan Yuhang, Lyu Hongpeng, Teng Fei, Dai Zhiqing, Lin Jin, Jia Hongxiao. A comparative study on the differences in cognitive functions between Fire Element and Water Element among the Five Element people [J]. Journal of Capital Medical University, 2024, 45(1): 111-117.
[10]	Zhong Jie, Zhu Hong, Hao Jun, Jia Hongxiao. The mediating effect of theory of mind between psychotic symptoms and social functioning in stable schizophrenia [J]. Journal of Capital Medical University, 2023, 44(4): 590-595.
[11]	Gao Xia, Hu Yanjin, Yao Zhi, Wang Guang. Correlation between triglyceride glucose index and severity of coronary artery disease in patients with newly diagnosed coronary heart disease [J]. Journal of Capital Medical University, 2023, 44(3): 381-386.
[12]	Li Mingjia, Zhao Miaomiao , Yang Jinkui . Research progress of cathepsin in the mechanism of diabetes and diabetic nephropathy [J]. Journal of Capital Medical University, 2023, 44(3): 413-419.